Study wrapper · #230
Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.
Editor's note
This is an analytical-chemistry paper, not a study of what these peptides do in the body. The researchers developed and validated a laboratory method (nano-liquid chromatography with high-resolution mass spectrometry) to detect GHRH analogues, sermorelin/CJC-1293, tesamorelin, and CJC-1295, plus a sermorelin metabolite in urine, meeting World Anti-Doping Agency requirements. The work's value is forensic: these peptides are prohibited in sport and are hard to catch because they are unstable, cleared quickly, and present at very low urinary concentrations, which this method addresses (detection limits of 0.5 ng/mL or less). For readers, the relevant takeaways are contextual rather than clinical: these compounds are banned in competition and are now detectable in anti-doping testing. The paper reports nothing about efficacy, safety, or dosing of Tesamorelin, Sermorelin, or CJC-1295, and should not be read as evidence of benefit or harm.
Plain-language abstract
This study is about detecting drugs, not about their effects. Certain lab-made peptides related to growth-hormone-releasing hormone (GHRH), including sermorelin, tesamorelin, and CJC-1295, are banned in sport by the World Anti-Doping Agency. They are hard to detect in urine because they break down quickly, are cleared from the body fast, and appear only at tiny concentrations. The researchers built and tested a sensitive laboratory technique, combining a miniaturised form of liquid chromatography with high-resolution mass spectrometry, to screen for and confirm these peptides and a breakdown product of sermorelin in urine. They carefully refined the sample clean-up steps and validated the method against anti-doping standards, checking things like sensitivity, reliability, and interference. The method could reliably detect the target peptides at very low levels (0.5 nanograms per millilitre or less). The authors concluded it is suitable and robust for anti-doping testing. The study does not examine whether these peptides work or are safe; it only provides a way to detect their use.